Hmdb loader
Survey
You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on Human Metabolome Database.
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2012-09-06 15:00:11 UTC
Update Date2020-02-26 21:39:07 UTC
HMDB IDHMDB0013842
Secondary Accession Numbers
  • HMDB13842
Metabolite Identification
Common NameO-Deethylated candesartan
DescriptionO-Deethylated candesartan is only found in individuals that have used or taken Candesartan.O-Deethylated candesartan is a metabolite of Candesartan. O-deethylated candesartan belongs to the family of Biphenyltetrazoles and Derivatives. These are organic compounds containing a biphenyl attached to a tetrazole. A carbon atom of the biphenyl moiety is boned to a carbon or the nitrogen atom of the tetrazole moiety.
Structure
Data?1582753147
Synonyms
ValueSource
2-Hydroxy-1-{[2'-(2H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-1,3-benzodiazole-7-carboxylateGenerator
Chemical FormulaC22H16N6O3
Average Molecular Weight412.4008
Monoisotopic Molecular Weight412.128388408
IUPAC Name2-hydroxy-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-1,3-benzodiazole-7-carboxylic acid
Traditional Name2-hydroxy-3-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-benzodiazole-4-carboxylic acid
CAS Registry NumberNot Available
SMILES
OC(=O)C1=C2N(CC3=CC=C(C=C3)C3=CC=CC=C3C3=NNN=N3)C(O)=NC2=CC=C1
InChI Identifier
InChI=1S/C22H16N6O3/c29-21(30)17-6-3-7-18-19(17)28(22(31)23-18)12-13-8-10-14(11-9-13)15-4-1-2-5-16(15)20-24-26-27-25-20/h1-11H,12H2,(H,23,31)(H,29,30)(H,24,25,26,27)
InChI KeyKLCPKPIDOPBIQW-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as biphenyls and derivatives. These are organic compounds containing to benzene rings linked together by a C-C bond.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassBiphenyls and derivatives
Direct ParentBiphenyls and derivatives
Alternative Parents
Substituents
  • Biphenyl
  • Phenyltetrazole
  • Benzimidazole
  • N-substituted imidazole
  • Azole
  • Imidazole
  • Heteroaromatic compound
  • Tetrazole
  • Vinylogous amide
  • Urea
  • Carboxylic acid derivative
  • Carboxylic acid
  • Monocarboxylic acid or derivatives
  • Azacycle
  • Organoheterocyclic compound
  • Organic oxygen compound
  • Organic oxide
  • Organic nitrogen compound
  • Hydrocarbon derivative
  • Organonitrogen compound
  • Organooxygen compound
  • Organopnictogen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility0.017 g/LALOGPS
logP3.27ALOGPS
logP4.56ChemAxon
logS-4.4ALOGPS
pKa (Strongest Acidic)3ChemAxon
pKa (Strongest Basic)1.82ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count7ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area129.81 ŲChemAxon
Rotatable Bond Count5ChemAxon
Refractivity125.69 m³·mol⁻¹ChemAxon
Polarizability41.27 ųChemAxon
Number of Rings5ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+193.48331661259
DarkChem[M-H]-191.02131661259
DeepCCS[M+H]+200.01730932474
DeepCCS[M-H]-197.65930932474
DeepCCS[M-2H]-230.56630932474
DeepCCS[M+Na]+206.1130932474
AllCCS[M+H]+199.032859911
AllCCS[M+H-H2O]+196.332859911
AllCCS[M+NH4]+201.432859911
AllCCS[M+Na]+202.132859911
AllCCS[M-H]-195.132859911
AllCCS[M+Na-2H]-194.332859911
AllCCS[M+HCOO]-193.632859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
O-Deethylated candesartanOC(=O)C1=C2N(CC3=CC=C(C=C3)C3=CC=CC=C3C3=NNN=N3)C(O)=NC2=CC=C15287.2Standard polar33892256
O-Deethylated candesartanOC(=O)C1=C2N(CC3=CC=C(C=C3)C3=CC=CC=C3C3=NNN=N3)C(O)=NC2=CC=C13726.5Standard non polar33892256
O-Deethylated candesartanOC(=O)C1=C2N(CC3=CC=C(C=C3)C3=CC=CC=C3C3=NNN=N3)C(O)=NC2=CC=C14289.1Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
O-Deethylated candesartan,1TMS,isomer #1C[Si](C)(C)OC(=O)C1=CC=CC2=C1N(CC1=CC=C(C3=CC=CC=C3C3=N[NH]N=N3)C=C1)C(O)=N24072.1Semi standard non polar33892256
O-Deethylated candesartan,1TMS,isomer #2C[Si](C)(C)OC1=NC2=CC=CC(C(=O)O)=C2N1CC1=CC=C(C2=CC=CC=C2C2=N[NH]N=N2)C=C13953.7Semi standard non polar33892256
O-Deethylated candesartan,1TMS,isomer #3C[Si](C)(C)N1N=NC(C2=CC=CC=C2C2=CC=C(CN3C(O)=NC4=CC=CC(C(=O)O)=C43)C=C2)=N14321.9Semi standard non polar33892256
O-Deethylated candesartan,2TMS,isomer #1C[Si](C)(C)OC(=O)C1=CC=CC2=C1N(CC1=CC=C(C3=CC=CC=C3C3=N[NH]N=N3)C=C1)C(O[Si](C)(C)C)=N23882.5Semi standard non polar33892256
O-Deethylated candesartan,2TMS,isomer #2C[Si](C)(C)OC(=O)C1=CC=CC2=C1N(CC1=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C)N=N3)C=C1)C(O)=N24192.5Semi standard non polar33892256
O-Deethylated candesartan,2TMS,isomer #3C[Si](C)(C)OC1=NC2=CC=CC(C(=O)O)=C2N1CC1=CC=C(C2=CC=CC=C2C2=NN([Si](C)(C)C)N=N2)C=C14125.9Semi standard non polar33892256
O-Deethylated candesartan,3TMS,isomer #1C[Si](C)(C)OC(=O)C1=CC=CC2=C1N(CC1=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C)N=N3)C=C1)C(O[Si](C)(C)C)=N24036.3Semi standard non polar33892256
O-Deethylated candesartan,3TMS,isomer #1C[Si](C)(C)OC(=O)C1=CC=CC2=C1N(CC1=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C)N=N3)C=C1)C(O[Si](C)(C)C)=N23847.1Standard non polar33892256
O-Deethylated candesartan,3TMS,isomer #1C[Si](C)(C)OC(=O)C1=CC=CC2=C1N(CC1=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C)N=N3)C=C1)C(O[Si](C)(C)C)=N24929.9Standard polar33892256
O-Deethylated candesartan,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)C1=CC=CC2=C1N(CC1=CC=C(C3=CC=CC=C3C3=N[NH]N=N3)C=C1)C(O)=N24292.6Semi standard non polar33892256
O-Deethylated candesartan,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC1=NC2=CC=CC(C(=O)O)=C2N1CC1=CC=C(C2=CC=CC=C2C2=N[NH]N=N2)C=C14176.8Semi standard non polar33892256
O-Deethylated candesartan,1TBDMS,isomer #3CC(C)(C)[Si](C)(C)N1N=NC(C2=CC=CC=C2C2=CC=C(CN3C(O)=NC4=CC=CC(C(=O)O)=C43)C=C2)=N14454.9Semi standard non polar33892256
O-Deethylated candesartan,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)C1=CC=CC2=C1N(CC1=CC=C(C3=CC=CC=C3C3=N[NH]N=N3)C=C1)C(O[Si](C)(C)C(C)(C)C)=N24250.4Semi standard non polar33892256
O-Deethylated candesartan,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC(=O)C1=CC=CC2=C1N(CC1=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C(C)(C)C)N=N3)C=C1)C(O)=N24491.9Semi standard non polar33892256
O-Deethylated candesartan,2TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC1=NC2=CC=CC(C(=O)O)=C2N1CC1=CC=C(C2=CC=CC=C2C2=NN([Si](C)(C)C(C)(C)C)N=N2)C=C14429.3Semi standard non polar33892256
O-Deethylated candesartan,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)C1=CC=CC2=C1N(CC1=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C(C)(C)C)N=N3)C=C1)C(O[Si](C)(C)C(C)(C)C)=N24496.0Semi standard non polar33892256
O-Deethylated candesartan,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)C1=CC=CC2=C1N(CC1=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C(C)(C)C)N=N3)C=C1)C(O[Si](C)(C)C(C)(C)C)=N24453.7Standard non polar33892256
O-Deethylated candesartan,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)C1=CC=CC2=C1N(CC1=CC=C(C3=CC=CC=C3C3=NN([Si](C)(C)C(C)(C)C)N=N3)C=C1)C(O[Si](C)(C)C(C)(C)C)=N24955.6Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - O-Deethylated candesartan GC-MS (Non-derivatized) - 70eV, Positivesplash10-001r-0379000000-5499e9be1a07b5f10ae02017-09-01Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - O-Deethylated candesartan GC-MS (2 TMS) - 70eV, Positivesplash10-000i-2092530000-a4822fa98beb536c354d2017-10-06Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - O-Deethylated candesartan GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - O-Deethylated candesartan 10V, Positive-QTOFsplash10-03di-0036900000-d434abb2699f10d13c7a2016-06-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - O-Deethylated candesartan 20V, Positive-QTOFsplash10-029j-0359200000-a36571eff1fbc2036e972016-06-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - O-Deethylated candesartan 40V, Positive-QTOFsplash10-000i-1690000000-2eb338d92f7e70c54f8c2016-06-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - O-Deethylated candesartan 10V, Negative-QTOFsplash10-02t9-0409600000-1f87cbea80b2c88504142016-08-04Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - O-Deethylated candesartan 20V, Negative-QTOFsplash10-0159-0609100000-e755b003e65047bbdcd12016-08-04Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - O-Deethylated candesartan 40V, Negative-QTOFsplash10-001i-0900000000-cde4a4a4e9414ced30842016-08-04Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - O-Deethylated candesartan 10V, Negative-QTOFsplash10-02t9-0009500000-79b412d0c98c1e98ac362021-09-23Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - O-Deethylated candesartan 20V, Negative-QTOFsplash10-0159-0409300000-90e929d44f10dc3d79d12021-09-23Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - O-Deethylated candesartan 40V, Negative-QTOFsplash10-001i-0900000000-1a47ce6f5e06a811409f2021-09-23Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - O-Deethylated candesartan 10V, Positive-QTOFsplash10-03di-0001900000-1b1730a47bfd07c6c1662021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - O-Deethylated candesartan 20V, Positive-QTOFsplash10-0ap1-0029100000-117f2e189d744333e2042021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - O-Deethylated candesartan 40V, Positive-QTOFsplash10-0a4i-0795000000-ca1f7b7a6814881b105d2021-09-25Wishart LabView Spectrum
Biological Properties
Cellular Locations
  • Extracellular
Biospecimen Locations
  • Blood
  • Urine
Tissue Locations
  • Kidney
  • Liver
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry details
UrineExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID8222850
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound10047287
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General ReferencesNot Available

Enzymes

General function:
Involved in transferase activity, transferring hexosyl groups
Specific function:
UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds.
Gene Name:
UGT1A3
Uniprot ID:
P35503
Molecular weight:
60337.835
References
  1. Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
General function:
Involved in peroxidase activity
Specific function:
May play an important role in regulating or promoting cell proliferation in some normal and neoplastically transformed cells.
Gene Name:
PTGS1
Uniprot ID:
P23219
Molecular weight:
68685.82
References
  1. Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
General function:
Involved in monooxygenase activity
Specific function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. This enzyme contributes to the wide pharmacokinetics variability of the metabolism of drugs such as S-warfarin, diclofenac, phenytoin, tolbutamide and losartan.
Gene Name:
CYP2C9
Uniprot ID:
P11712
Molecular weight:
55627.365
References
  1. McClellan KJ, Goa KL: Candesartan cilexetil. A review of its use in essential hypertension. Drugs. 1998 Nov;56(5):847-69. [PubMed:9829158 ]
  2. Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
  3. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
General function:
Involved in monooxygenase activity
Specific function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. In the epoxidation of arachidonic acid it generates only 14,15- and 11,12-cis-epoxyeicosatrienoic acids. It is the principal enzyme responsible for the metabolism the anti-cancer drug paclitaxel (taxol).
Gene Name:
CYP2C8
Uniprot ID:
P10632
Molecular weight:
55824.275
References
  1. Walsky RL, Gaman EA, Obach RS: Examination of 209 drugs for inhibition of cytochrome P450 2C8. J Clin Pharmacol. 2005 Jan;45(1):68-78. [PubMed:15601807 ]
General function:
Involved in G-protein coupled receptor protein signaling pathway
Specific function:
Receptor for angiotensin II. Mediates its action by association with G proteins that activate a phosphatidylinositol- calcium second messenger system
Gene Name:
AGTR1
Uniprot ID:
P30556
Molecular weight:
41060.5
References
  1. Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. [PubMed:11752352 ]
  2. Cervenka L, Navar LG: Renal responses of the nonclipped kidney of two-kidney/one-clip Goldblatt hypertensive rats to type 1 angiotensin II receptor blockade with candesartan. J Am Soc Nephrol. 1999 Jan;10 Suppl 11:S197-201. [PubMed:9892163 ]
  3. Malmqvist K, Kahan T, Dahl M: Angiotensin II type 1 (AT1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide. Am J Hypertens. 2000 May;13(5 Pt 1):504-11. [PubMed:10826401 ]
  4. Wada T, Inada Y, Ojima M, Sanada T, Shibouta Y, Nishikawa K: Comparison of the antihypertensive effects of the new angiotensin II (AT1) receptor antagonist candesartan cilexetil (TCV-116) and the angiotensin converting enzyme inhibitor enalapril in rats. Hypertens Res. 1996 Jun;19(2):75-81. [PubMed:10968199 ]
  5. Engelhorn T, Doerfler A, Heusch G, Schulz R: Reduction of cerebral infarct size by the AT1-receptor blocker candesartan, the HMG-CoA reductase inhibitor rosuvastatin and their combination. An experimental study in rats. Neurosci Lett. 2006 Oct 2;406(1-2):92-6. Epub 2006 Aug 9. [PubMed:16901636 ]
  6. Caballero-George C, Vanderheyden PM, Solis PN, Gupta MP, Pieters L, Vauquelin G, Vlietinck A: In vitro effect of sanguinarine alkaloid on binding of [3H]candesartan to the human angiotensin AT1 receptor. Eur J Pharmacol. 2003 Jan 5;458(3):257-62. [PubMed:12504781 ]
  7. McInnes GT, O'Kane KP, Istad H, Keinanen-Kiukaanniemi S, Van Mierlo HF: Comparison of the AT1-receptor blocker, candesartan cilexetil, and the ACE inhibitor, lisinopril, in fixed combination with low dose hydrochlorothiazide in hypertensive patients. J Hum Hypertens. 2000 Apr;14(4):263-9. [PubMed:10805052 ]
  8. Vauquelin G, Fierens F, Van Liefde I: Long-lasting angiotensin type 1 receptor binding and protection by candesartan: comparison with other biphenyl-tetrazole sartans. J Hypertens Suppl. 2006 Mar;24(1):S23-30. [PubMed:16601569 ]
  9. Mendis B, Page SR: Candesartan: widening indications for this angiotensin II receptor blocker? Expert Opin Pharmacother. 2009 Aug;10(12):1995-2007. doi: 10.1517/14656560903092197. [PubMed:19563275 ]
  10. Meredith PA: Candesartan cilexetil--a review of effects on cardiovascular complications in hypertension and chronic heart failure. Curr Med Res Opin. 2007 Jul;23(7):1693-705. [PubMed:17588300 ]
  11. Baguet JP, Barone-Rochette G, Neuder Y: Candesartan cilexetil in the treatment of chronic heart failure. Vasc Health Risk Manag. 2009;5(1):257-64. Epub 2009 Apr 8. [PubMed:19436650 ]

Transporters

General function:
Involved in ATP binding
Specific function:
Energy-dependent efflux pump responsible for decreased drug accumulation in multidrug-resistant cells
Gene Name:
ABCB1
Uniprot ID:
P08183
Molecular weight:
141477.3
References
  1. Takara K, Kakumoto M, Tanigawara Y, Funakoshi J, Sakaeda T, Okumura K: Interaction of digoxin with antihypertensive drugs via MDR1. Life Sci. 2002 Feb 15;70(13):1491-500. [PubMed:11895100 ]